Tiglutik Liquid
NDC Package 70726-0303-1
Package Information
Tiglutik (riluzole) liquids is tIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS). This formulation utilizes a liquid delivery system. Marketed by Edw Pharma, Inc, this product is identified by NDC 70726-0303 and is authorized under FDA application NDA209080.
Identification & Billing
- RxCUI: 2058147 - riluzole 50 MG in 10 mL Oral Suspension
- RxCUI: 2058147 - riluzole 5 MG/ML Oral Suspension
- RxCUI: 2058147 - riluzole 25 MG per 5 mL Oral Suspension
- RxCUI: 2058147 - riluzole 50 MG per 10 mL Oral Suspension
- RxCUI: 2059266 - Tiglutik 50 MG in 10 mL Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70726 - Edw Pharma, Inc
- 70726-0303 - Tiglutik
- 70726-0303-1 - 2 BOTTLE, PLASTIC in 1 CARTON / 300 mL in 1 BOTTLE, PLASTIC (70726-0303-2)
- 70726-0303 - Tiglutik
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70726-0303-1 identifies a specific commercial package of 2 bottle, plastic in 1 carton / 300 ml in 1 bottle, plastic (70726-0303-2) of Tiglutik, a human prescription drug labeled by Edw Pharma, Inc. This product is billed per "ML" milliliter and contains an estimated amount of 600 billable units per package. This liquid is formulated for oral use and contains riluzole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Edw Pharma, Inc on September 21, 2018. The current certification is valid through December 31, 2027.
How is this Edw Pharma, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70726030301. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 600 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.